Glutathione Peroxidase 1 Activity and Cardiovascular Events in Patients with Coronary Artery Disease

New England Journal of Medicine

Volumn 349, Issue 17, 2003, Pages 1605-1613

  Blankenberg, Stefan ^a,b   Rupprecht, Hans J ^a   Bickel, Christoph ^c   Torzewski, Michael ^a   Hafner, Gerd ^a   Tiret, Laurence ^b   Smieja, Marek ^d   Cambien, François ^b   Meyer, Jürgen ^a   Lackner, Karl J ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c Innere Abteilung   (Germany)

^d MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTATHIONE PEROXIDASE; GLUTATHIONE PEROXIDASE 1; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; ENZYME ACTIVITY; ERYTHROCYTE; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SMOKING;

AGED; ANALYSIS OF VARIANCE; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; CORONARY ARTERIOSCLEROSIS; ERYTHROCYTES; FEMALE; GLUTATHIONE PEROXIDASE; HUMANS; MALE; PROSPECTIVE STUDIES; RISK; SEX FACTORS; SMOKING; SUPEROXIDE DISMUTASE; SURVIVAL ANALYSIS;

EID: 0142057430     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJMoa030535     Document Type: Article

References (38)

1. Ross R. Atherosclerosis - an inflammatory disease. N Engl J Med 1999;340:115-26.
2. Glass CK, Witztum JL. Atherosclerosis: the road ahead. Cell 2001;104:503-16.
3. Steinberg D, Witztum JL. Is the oxidative modification hypothesis relevant to human atherosclerosis? Do the antioxidant trials conducted to date refute the hypothesis? Circulation 2002;105:2107-11.
4. Forsberg L, de Faire U, Morgenstern R. Oxidative stress, human genetic variation, and disease. Arch Biochem Biophys 2001;389:84-93.
5. Ursini F, Maiorino M, Brigelius-Flohe R, et al. Diversity of glutathione peroxidases. Methods Enzymol 1995;252:38-53.
6. Raes M, Michiels C, Kemacle J. Comparative study of the enzymatic defense systems against oxygen-derived free radicals: the key role of glutathione peroxidase. Free Radic Biol Med 1987;3:3-7.
7. Arthur JR. The glutathione peroxidases. Cell Mol Life Sci 2000;57:1825-35.
8. Flohe L. Glutathione peroxidase. Basic Life Sci 1988;49:663-8.
9. Sies H. Glutathione and its role in cellular functions. Free Radic Biol Med 1999;27:916-21.
10. Forgione MA, Cap A, Liao R, et al. Heterozygous cellular glutathione peroxidase deficiency in the mouse: abnormalities in vascular and cardiac function and structure. Circulation 2002;106:1154-8.
11. Fukai T, Folz RJ, Landmesser U, Harrison DG. Extracellular superoxide dismutase and cardiovascular disease. Cardiovasc Res 2002;55:239-49.
12. Kupprecht HJ, Blankenberg S, Bickel C, et al. Impact of viral and bacterial infectious burden on long-term prognosis in patients with coronary artery disease. Circulation 2001;104:25-31.
13. Paglia DE, Valentine WN. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 1967;70:158-69.
14. Oster O, Prellwitz W. A methodological comparison of hydride and carbon furnace atomic absorption spectroscopy for the determination of selenium in serum. Clin Chim Acta 1982;124:277-91.
15. Guo Z, Van Remmen H, Yang H, et al. Changes in expression of antioxidant enzymes affect cell-mediated LDL oxidation and oxidized LDL-induced apoptosis in mouse aortic cells. Arterioscler Thromb Vasc Biol 2001;21:1131-8.
16. Forgione MA, Weiss N, Heydrick S, et al. Cellular glutathione peroxidase deficiency and endothelial dysfunction. Am J Physiol Heart Circ Physiol 2002;282:H1255-H1261.
17. Dayal S, Brown KL, Weydert CJ, et al. Deficiency of glutathione peroxidase-1 sensitizes hyperhomocysteinemic mice to endothelial dysfunction. Arterioscler Thromb Vasc Biol 2002;22:1996-2002.
18. Lapenna D, de Gioia S, Ciofani G, et al. Glutathione-related antioxidant defenses in human atherosclerotic plaques. Circulation 1998;97:1930-4.
19. Shingu M, Yoshioka K, Nobunaga M, Yoshida K. Human vascular smooth muscle cells and endothelial cells lack catalase activity and are susceptible to hydrogen peroxide. Inflammation 1985;9:309-20.
20. Andersen HR, Nielsen JB, Nielsen F, Grandjean P. Antioxidative enzyme activities in human erythrocytes. Clin Chem 1997;43:562-8.
21. Forsberg L, de Faire U, Marklund SL, Andersson PM, Stegmayr B, Morgenstern R, Phenotype determination of a common Pro-Leu polymorphism in human glutathione peroxidase 1. Blood Cells Mol Dis 2000;26:423-6.
22. Massafra C, Gioia D, De Felice C, Muscettola M, Longini M, Buonocore G. Gender-related differences in erythrocyte glutathione peroxidase activity in healthy subjects. Clin Endocrinol (Oxf) 2002;57:663-7.
23. Su Y, Han W, Giraldo C, De Li Y, Block ER. Effect of cigarette smoke extract on nitric oxide synthase in pulmonary artery endothelial cells. Am J Respir Cell Mol Biol 1998;19:819-25.
24. Mulholland CW, Elwood PC, Davis A, et al. Antioxidant enzymes, inflammatory indices and lifestyle factors in older men: a cohort analysis. QJM 1999;92:579-85.
25. Straif D, Werz O, Kellner R, Bahr U, Steinhilber D. Glutathione peroxidase-1 but not -4 is involved in the regulation of cellular 5-lipoxygenase activity in monocytic cells. Biochem J 2000;349:455-61.
26. Spanbroek R, Grabner R, Lotzer K, et al. Expanding expression of the 5-lipoxygenase pathway within the arterial wall during human atherogenesis. Proc Natl Acad Sci U S A 2003;100:1238-43.
27. Mehrabian M, Allayee H, Wong J, et al. Identification of 5-lipoxygenase as a major gene contributing to atherosclerosis susceptibility in mice. Circ Res 2002;91:120-6. [Erratum, Circ Res 2002;91:e27.]
28. Mehrabian M, Allayee H, Wong J, et al. Identification of 5-lipoxygenase as a major gene contributing to atherosclerosis susceptibility in mice. Circ Res 2002;91:120-6. [Erratum, Circ Res 2002;91:e27.]
29. Hussein O, Rosenblat M, Refael G, Aviram M. Dietary selenium increases cellular glutathione peroxidase activity and reduces the enhanced susceptibility to lipid peroxidation of plasma and low-density lipoprotein in kidney transplant recipients. Transplantation 1997;63:679-85.
30. Liu D, Liu S, Huang Y, Liu Y, Zhang Z, Han L. Effect of selenium on human myocardial glutathione peroxidase gene expression. Chin Med J (Engl) 2000;113:771-5.
31. Salonen JT, Salonen R, Seppanen K, et al. Relationship of serum selenium and antioxidants to plasma lipoproteins, platelet aggregability and prevalent ischaemic heart disease in Eastern Finnish men. Atherosclerosis 1988;70:155-60.
32. Suadicani P, Hein HO, Gyntelberg F. Serum selenium concentration and risk of ischaemic heart disease in a prospective cohort study of 3000 males. Atherosclerosis 1992;96:33-42.
33. Salvini S, Hennekens CH, Morris JS, Wilett WC, Stampfer MJ. Plasma levels of the antioxidant selenium and risk of myocardial infarction among U.S. physicians. Am J Cardiol 1995;76:1218-21.
34. Rayman MP. The importance of selenium to human health. Lancet 2000;356:233-41.
35. Alissa EM, Bahijri SM, Ferns GA. The controversy surrounding selenium and cardiovascular disease: a review of the evidence. Med Sci Monit 2003;9:RA9-RA18.
36. Kardinaal AF, Kok FJ, Kohlmeier L, et al. Association between toenail selenium and risk of acute myocardial infarction in European men: the EURAMIC Study: European Antioxidant Myocardial Infarction and Breast Cancer. Am J Epidemiol 1997;145:373-9.
37. Blankenberg S, Tiret L, Bickel C, et al. Interleukin-18 is a strong predictor of cardiovascular death in stable and unstable angina. Circulation 2002;106:24-30.
38. Blankenberg S, Rupprecht HJ, Bickel C, et al. Circulating cell adhesion molecules and death in patients with coronary artery disease. Circulation 2001;104:1336-42.